Retrospective Study of Patients With Type 2 Diabetes Mellitus on Dapagliflozin Therapy in Taiwan
Phase of Trial: Phase IV
Latest Information Update: 18 Sep 2017
At a glance
- Drugs Dapagliflozin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors AstraZeneca
- 12 Jun 2017 Status changed from not yet recruiting to recruiting.
- 18 May 2017 Planned initiation date changed from 10 Apr 2017 to 9 Jun 2017.
- 23 Mar 2017 New trial record